Two Sigma Securities’s Cocrystal Pharma COCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,255
Closed -$15.4K 1822
2026
Q1
$15.4K Buy
15,255
+2,503
+20% +$2.58K ﹤0.01% 1411
2025
Q4
$12.5K Buy
+12,752
New +$13.5K ﹤0.01% 1262
2022
Q4
Sell
-1,668
Closed -$6K 2671
2022
Q3
$6K Buy
1,668
+604
+57% +$2.83K ﹤0.01% 2462
2022
Q2
$5K Buy
+1,064
New +$5.67K ﹤0.01% 2109
2022
Q1
Sell
-3,306
Closed -$26K 2160
2021
Q4
$26K Buy
3,306
+1,808
+121% +$18.5K ﹤0.01% 1380
2021
Q3
$19K Buy
+1,498
New +$19.8K ﹤0.01% 1464

Other funds holding COCP

Two Sigma Securities's COCP Position: Q2 2026 in Review

Two Sigma Securities sold out of Cocrystal Pharma (COCP) in Q2 2026, closing a stake of 15,255 shares — an estimated $15.4K sold.

Two Sigma Securities first reported a position in COCP in Q3 2021 and held it in 6 quarters. The position peaked at $26K in Q4 2021. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Two Sigma Securities reported no remaining Cocrystal Pharma position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 15,255 Cocrystal Pharma shares in Q2 2026, an estimated $15.4K.
  • Two Sigma Securities first reported a position in Cocrystal Pharma in Q3 2021 and held it in 6 quarters.
  • Two Sigma Securities's Cocrystal Pharma position peaked at $26K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.